Fludarabine and Rituximab Produces Extended OS & PFS

[Guest guest]

This is a long term follow up on the CALGB 9712 FR trial.

An estimated 13% remained free of progression at almost 10 years of follow-up.

The study concludes;

" These long-term data support fludarabine plus rituximab as one acceptable

first-line treatment for symptomatic patients with CLL. "

Abstract:

http://jco.ascopubs.org/content/early/2011/02/14/JCO.2010.31.1811

~chris

[Guest guest]

I had FR in 2000 and enjoyed no problems until the last few years.

In a message dated 2/16/2011 1:08:32 P.M. Eastern Standard Time,

cllcanada@... writes:

This is a long term follow up on the CALGB 9712 FR trial.

An estimated 13% remained free of progression at almost 10 years of

follow-up.

The study concludes;

" These long-term data support fludarabine plus rituximab as one acceptable

first-line treatment for symptomatic patients with CLL. "

Abstract:

_http://jco.ascopubs.org/content/early/2011/02/14/JCO.2010.31.1811_

(http://jco.ascopubs.org/content/early/2011/02/14/JCO.2010.31.1811)

~chris